The 2020 revision of the guidelines for the management of myeloproliferative neoplasms-Reference-Cited by-同舟云学术

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms

Published:2021-01-01 Issue:1 Volume:36 Page:45-62
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Sung-Yong,Bae Sung Hwa,Bang Soo-Mee,Eom Ki-Seong,Hong Junshik,Jang Seongsoo,Jung Chul Won,Kim Hee-Jin,Kim Ho Young,Kim Min Kyoung,Kim Soo-Jeong,Mun Yeung-Chul,Nam Seung-Hyun,Park Jinny,Won Jong-Ho,Choi Chul Won

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2020-319.pdf

Reference128 articles.

1. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

3. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea

4. Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelofibrosis and anemia: A German claims data analysis to describe epidemiology and current treatment;European Journal of Haematology;2024-08-05

2. Myelodysplastic/Myeloproliferative Neoplasms with Features Intermediate between Primary Myelofibrosis and Chronic Myelomonocytic Leukemia: Case Series and Review of the Entity;Hemato;2024-07-07

3. Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity;Journal of Clinical Medicine;2024-05-14

4. Use of direct oral anticoagulants in hematologic malignancies;Thrombosis Update;2023-12

5. Marked reactive thrombocytosis in a female with iron deficiency anaemia;BMJ Case Reports;2023-11